It was noteworthy that Myc expression (66.18%) in our study was significantly higher in PB-DLBCL patients than DLBCL patients (30% of MYC gene expression in TCGA database; 20-30% of Myc protein expression as previously reported). The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.